Cyclophosphamide and Rotator cuff syndrome - a phase IV clinical study of FDA data

Summary:

Rotator cuff syndrome is reported as a side effect among people who take Cyclophosphamide (cyclophosphamide), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Prednisone, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Rotator cuff syndrome when taking Cyclophosphamide. It is created by eHealthMe based on reports of 185,094 people who have side effects when taking Cyclophosphamide from the FDA, and is updated regularly.

What is Cyclophosphamide?

Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.

What is Rotator cuff syndrome?

Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder) is found to be associated with 1,089 drugs and 1,120 conditions by eHealthMe. Check the latest studies of Rotator cuff syndrome.

On Jul, 09, 2026

185,094 people reported to have side effects when taking Cyclophosphamide.
Among them, 63 people (0.03%) have Rotator cuff syndrome.

Could Cyclophosphamide cause Rotator cuff syndrome?

Among these 63 people:

How long have people been on Cyclophosphamide when they have Rotator cuff syndrome? *

What is the gender of people who have Rotator cuff syndrome when taking Cyclophosphamide? *

female: 69.81 %
male: 30.19 %

What is the age of people who have Rotator cuff syndrome when taking Cyclophosphamide? *

What are other drugs people take besides Cyclophosphamide? *

What are other side effects people have besides Rotator cuff syndrome? *

Anaemia (lack of blood): 47 people, 74.60%
Pain: 45 people, 71.43%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 42 people, 66.67%
Fatigue (feeling of tiredness): 37 people, 58.73%
Fever: 37 people, 58.73%
Rashes (redness): 34 people, 53.97%
Joint Pain: 34 people, 53.97%
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 33 people, 52.38%
Dyspnea Exertional: 33 people, 52.38%
Haemoglobin Decreased: 32 people, 50.79%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 24 people, 38.10%
Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 23 people, 36.51%
Pain: 11 people, 17.46%
Antinuclear Antibody Positive: 10 people, 15.87%
Depression: 9 people, 14.29%
Prothrombin Level Abnormal: 8 people, 12.70%
Non-Hodgkin's Lymphoma Stage Iii (malignant (cancer) cells form in the lymph system- stage iii): 8 people, 12.70%
Nausea (feeling of having an urge to vomit): 3 people, 4.76%
Irritability: 3 people, 4.76%
Erection Problems: 3 people, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Cyclophosphamide and have Rotator cuff syndrome?

- Check whether Rotator cuff syndrome is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cyclophosphamide:

Cyclophosphamide (185,240 reports)

Browse all side effects of Cyclophosphamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rotator cuff syndrome:

Rotator cuff syndrome (1,089 drugs)

Browse all the conditions that are associated with Rotator cuff syndrome:

Rotator cuff syndrome (1,120 conditions)

Related publications that referenced our studies

Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on cyclophosphamide (the active ingredients of Cyclophosphamide) and Cyclophosphamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.